Literature DB >> 2158791

Chronic ethanol and pentobarbital administration in the rat: effects on GABAA receptor function and expression in brain.

A L Morrow1, P Montpied, A Lingford-Hughes, S M Paul.   

Abstract

Chronic exposure of rats to ethanol significantly decrease GABAA receptor-mediated 36Cl- uptake in cerebral cortical synaptoneurosomes. Muscimol and pentobarbital stimulation as well as ethanol enhancement of muscimol-stimulated 36Cl- flux are significantly decreased following chronic ethanol inhalation. Repeated pentobarbital administration has a similar effect on muscimol and pentobarbital-stimulated 36Cl- uptake in cerebral cortical synaptoneurosomes. We have postulated that these adaptive response may be associated with an alteration of GABAA receptor gene expression. Chronic ethanol exposure resulted in a significant reduction in the levels of GABAA receptor alpha-subunit mRNA's. The most abundant mRNA species in the rat cerebral cortex were reduced 40-50% (4.4 Kb mRNA, 43%, 4.8 Kb mRNA, 47%). beta-Actin mRNA and poly(A)+ RNA levels were not significantly reduced following chronic ethanol exposure. Repeated pentobarbital administration had no effect on the level of the 4.4 and 4.8 Kb transcripts of alpha-subunit mRNAs in rat cerebral cortex. These data suggest that chronic ethanol exposure alters the level of mRNA's coding for the alpha-subunit of the GABAA receptor. This decrease may reflect an alteration of mRNA processing in the cell or an alteration in GABAA receptor gene expression.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2158791     DOI: 10.1016/0741-8329(90)90012-2

Source DB:  PubMed          Journal:  Alcohol        ISSN: 0741-8329            Impact factor:   2.405


  17 in total

1.  Update on the neurobiology of alcohol withdrawal seizures.

Authors:  Michael A Rogawski
Journal:  Epilepsy Curr       Date:  2005 Nov-Dec       Impact factor: 7.500

Review 2.  Stress, ethanol, and neuroactive steroids.

Authors:  Giovanni Biggio; Alessandra Concas; Paolo Follesa; Enrico Sanna; Mariangela Serra
Journal:  Pharmacol Ther       Date:  2007-05-08       Impact factor: 12.310

3.  Responding to acoustic startle during chronic ethanol intoxication and withdrawal.

Authors:  S Rassnick; G F Koob; M A Geyer
Journal:  Psychopharmacology (Berl)       Date:  1992       Impact factor: 4.530

Review 4.  Alcohol use disorders and current pharmacological therapies: the role of GABA(A) receptors.

Authors:  Jing Liang; Richard W Olsen
Journal:  Acta Pharmacol Sin       Date:  2014-08       Impact factor: 6.150

5.  Effects of 7-keto dehydroepiandrosterone on voluntary ethanol intake in male rats.

Authors:  Mary E Worrel; Olga V Gurkovskaya; Stuart T Leonard; Peter B Lewis; Peter J Winsauer
Journal:  Alcohol       Date:  2010-11-04       Impact factor: 2.405

6.  Dihydromyricetin as a novel anti-alcohol intoxication medication.

Authors:  Yi Shen; A Kerstin Lindemeyer; Claudia Gonzalez; Xuesi M Shao; Igor Spigelman; Richard W Olsen; Jing Liang
Journal:  J Neurosci       Date:  2012-01-04       Impact factor: 6.167

7.  The interaction between ethanol and pregnanolone at induction of anaesthesia investigated with a threshold method in male rats.

Authors:  M D Wang; D Zhu; T Bäckström; G Wahlström
Journal:  Br J Pharmacol       Date:  2001-12       Impact factor: 8.739

Review 8.  Neurosteroids, GABAA receptors, and ethanol dependence.

Authors:  Paolo Follesa; Francesca Biggio; Giuseppe Talani; Luca Murru; Mariangela Serra; Enrico Sanna; Giovanni Biggio
Journal:  Psychopharmacology (Berl)       Date:  2005-09-15       Impact factor: 4.530

9.  Acute and subchronic benzodiazepine-barbiturate-interactions on behaviour and physiological responses of the mouse.

Authors:  J Wolffgramm; C Mikolaiczyk; H Coper
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1994-03       Impact factor: 3.000

Review 10.  Alcoholism and alternative splicing of candidate genes.

Authors:  Toshikazu Sasabe; Shoichi Ishiura
Journal:  Int J Environ Res Public Health       Date:  2010-03-30       Impact factor: 3.390

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.